Life Sciences Service Architecture
The digital platform is engineered as a High-Authority Knowledge Hub, designed to translate complex molecular biology into a strategic commercial narrative. By structuring the site around "Mechanism of Action" and "Clinical Advantage," the architecture provides a clear pathway for investors and pharmaceutical partners to evaluate the firm’s lead therapeutic candidates. This approach ensures that the scientific rigor of the University spin-out is the primary driver of the user experience.
UX & Stakeholder Navigation
We utilised a "Data-First" design philosophy, removing interface friction to prioritise the delivery of preclinical evidence and technical milestones. The methodology focuses on a high-clarity navigation system that caters to a dual audience of academic researchers and private equity investors. By maintaining a clean, minimalist aesthetic, we ensured that the technical sophistication of the mAb platform is communicated with professional transparency and precision.
Strategic Validation & Trust Logic
The platform is built to amplify high-authority trust signals, integrating the firm’s academic heritage with its commercial achievements. We utilised a modular framework to showcase partnerships with major stakeholders such as Scottish Enterprise and the Wellcome Trust. This strategy shifts the narrative from "early-stage research" to "validated clinical solution," fostering immediate confidence in the firm’s ability to move anti-infective therapies toward first-in-human trials.
Operational Scalability & Global Presence
The website is underpinned by a robust technical framework designed to evolve alongside the firm’s clinical pipeline. By integrating dynamic news feeds and investor portals, we created a scalable digital environment that supports mycoBiologics’ transition from stealth-mode spin-out to a global biotech player. This technical foundation ensures a secure, high-fidelity presence that reflects the firm's mission to address one of the biggest current threats to global health.
